Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2024Clinical Infectious Diseases

Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

View Full Paper
Ask AI
Bookmark
Share

Authors

PTPranita D. TammaEHEmily L. HeilJJJulie Ann Justo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tamma et al. (2024) studied this question.

synapsesocial.com/papers/68e5d23bb6db643587567e76https://doi.org/10.1093/cid/ciae403
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii2006 · 766 citations
  2. 2Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients2009 · 302 citations
  3. 3Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study2021 · 275 citations
  4. 4Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study2023 · 45 citations
  5. 5Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study2013 · 79 citations